RVP

Drug Catalog - Product Detail

BUTALBITAL/ACETAMINOPHEN & CAFFEINE 50/325/40MG TB 100

NDC Mfr Size Str Form
10702-0253-01 KVK TECH 100 50-325-40MG TABLET
Product Image

PACKAGE FILES

Package Image
Package Image
Package Image
Package Image
Package Image
Package Image
Generic Name
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
Substance Name
ACETAMINOPHEN
Product Type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Application Number
ANDA211106
Description
DESCRIPTION Butalbital, Acetaminophen and Caffeine Tablets, USP are supplied in tablet form for oral administration. Each tablet contains the following active ingredients: butalbital, USP ...................................................................................... 50 mg acetaminophen, USP ............................................................................ 325 mg caffeine, USP ........................................................................................ 40 mg Inactive Ingredients: colloidal silicon dioxide, croscarmellose sodium, crospovidone, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid. Butalbital (5-allyl-5-isobutylbarbituric acid), is a short to intermediate-acting barbiturate. It has the following structural formula: Acetaminophen (4'-hydroxyacetanilide), is a non-opiate, non-salicylate analgesic and antipyretic. It has the following structural formula: Caffeine (1,3,7-trimethylxanthine), is a central nervous system stimulant. It has the following structural formula: butalbital-structure apap structure caffeine structure
How Supplied
HOW SUPPLIED Butalbital, Acetaminophen and Caffeine Tablets, USP containing 50 mg butalbital, 325 mg acetaminophen and 40 mg caffeine is available as white to off-white, round shaped, biconvex tablets, debossed "C17" on one side and plain on the other. Bottles of 100: NDC 10702-253-01 Bottles of 500: NDC 10702-253-50 Store and Dispense Store at 20° to 25°C (68° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]; dispense in a tight, light-resistant container as defined in the USP.
Indications & Usage
INDICATIONS AND USAGE Butalbital, acetaminophen and caffeine tablets are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.
Dosage and Administration
DOSAGE AND ADMINISTRATION One or 2 tablets every 4 hours as needed. Total daily dosage should not exceed 6 tablets. Extended and repeated use of this product is not recommended because of the potential for physical dependence.